Tissue ACE phenotyping in lung cancer

Autor: Eckhard Klieser, Roman Metzger, Ilya Trakht, Karl Sotlar, Joe G.N. Garcia, Sergei M. Danilov
Jazyk: angličtina
Rok vydání: 2019
Předmět:
Male
0301 basic medicine
Lung Neoplasms
Physiology
Squamous Cell Lung Carcinoma
Lung and Intrathoracic Tumors
Small Cell Lung Cancer
Epitopes
chemistry.chemical_compound
0302 clinical medicine
Adenocarcinomas
Carcinoma
Non-Small-Cell Lung

Medicine and Health Sciences
Lung
Multidisciplinary
Adenocarcinoma of the Lung
Squamous Cell Carcinomas
Antibodies
Monoclonal

Middle Aged
respiratory system
Immunohistochemistry
Body Fluids
Blood
Phenotype
medicine.anatomical_structure
Oncology
030220 oncology & carcinogenesis
Adenocarcinoma
Medicine
Female
Anatomy
Research Article
Science
Bradykinin
Peptidyl-Dipeptidase A
Carcinomas
03 medical and health sciences
Renin–angiotensin system
Adenocarcinoma of the lung
medicine
Humans
Lung cancer
Aged
business.industry
Cancers and Neoplasms
Biology and Life Sciences
medicine.disease
Small Cell Lung Carcinoma
Non-Small Cell Lung Cancer
030104 developmental biology
chemistry
Cancer research
Field cancerization
Secondary Lung Tumors
business
Zdroj: PLoS ONE, Vol 14, Iss 12, p e0226553 (2019)
PLoS ONE
ISSN: 1932-6203
Popis: Background Pulmonary vascular endothelium is the main metabolic site for Angiotensin I-Converting Enzyme (ACE)-mediated degradation of several biologically-active peptides (angiotensin I, bradykinin, hemo-regulatory peptide Ac-SDKP). Primary lung cancer growth and lung cancer metastases decrease lung vascularity reflected by dramatic decreases in both lung and serum ACE activity. We performed precise ACE phenotyping in tissues from subjects with lung cancer. Methodology ACE phenotyping included: 1) ACE immunohistochemistry with specific and well-characterized monoclonal antibodies (mAbs) to ACE; 2) ACE activity measurement with two ACE substrates (HHL, ZPHL); 3) calculation of ACE substrates hydrolysis ratio (ZPHL/HHL ratio); 4) the pattern of mAbs binding to 17 different ACE epitopes to detect changes in ACE conformation induced by tumor growth (conformational ACE fingerprint). Results ACE immunostaining was dramatically decreased in lung cancer tissues confirmed by a 3-fold decrease in ACE activity. The conformational fingerprint of ACE from tumor lung tissues differed from normal lung (6/17 mAbs) and reflected primarily higher ACE sialylation. The increase in ZPHL/HHL ratio in lung cancer tissues was consistent with greater conformational changes of ACE. Limited analysis of the conformational ACE fingerprint in normal lung tissue and lung cancer tissue form the same patient suggested a remote effect of tumor tissue on ACE conformation and/or on "field cancerization" in a morphologically-normal lung tissues. Conclusions/significance Local conformation of ACE is significantly altered in tumor lung tissues and may be detected by conformational fingerprinting of human ACE.
Databáze: OpenAIRE
Nepřihlášeným uživatelům se plný text nezobrazuje